Preparing your experience, please wait…
K
Clinical reviews
ORIGINAL ARTICLE
NTT Medical Center Tokyo
PDF9 pages1.3 MB
The research focuses on the renoprotective effects of ARNI in patients with CKD, highlighting a retrospective analysis of 89 patients who switched from renin–angiotensin system inhibitors to sacubitril/valsartan. The study evaluates changes in eGFR slope and blood pressure control before and after ARNI initiation. Results indicate a significant improvement in eGFR decline and blood pressure management, suggesting that ARNI therapy may be beneficial for patients with non-dialysis CKD.
No account needed
Discuss clinical evidence & guidelines
Examine in Ask OslerAsk this resource
Processing document…This document is still under processing for page-by-page Q&A. You can read or download the full document above, check back shortly, or search related documents that are already available.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
The Diagnosis And Management OfHepatorenal Syndrome
Same clinical topic · Nephrology
CONTRAST-ASSOCIATED ACUTE KIDNEY INJURY: COMPREHENSIVE REVIEW OF RISK FACTORS, PATHOPHYSIOLOGY, DEFINITION AND MANAGEMENT
Same clinical topic · Nephrology
ACUTE GLOMERULONEPHRITIS
Same clinical topic · Nephrology
RENAL THROMBOTIC MICROANGIOPATHY: A REVIEW
Same clinical topic · Nephrology
CURRENT OPTIONS FOR KIDNEY PROTECTION: ARE RENIN –ANGIOTENSIN SYSTEM INHIBITORS STILL RELEVANT?
Same clinical topic · Nephrology
TOWARD INDIVIDUALIZED CORRECTION IN HYPONATREMIA
Same clinical topic · Nephrology
ACUTE KIDNEY INJURY: PATHOGENESIS AND THERAPEUTIC INTERVENTIONS
Same clinical topic · Nephrology
IMPACT OF CREATINE SUPPLEMENTATION ON KIDNEY HEALTH: A SYSTEMATIC REVIEW AND META-ANALYSIS
Same clinical topic · Nephrology
Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic
Same clinical topic · Nephrology